1992
DOI: 10.1016/0165-5728(92)90042-j
|View full text |Cite
|
Sign up to set email alerts
|

Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

6
51
0

Year Published

1995
1995
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 149 publications
(57 citation statements)
references
References 29 publications
6
51
0
Order By: Relevance
“…In addition to antigen or anti-CD3-induced IFN-y production by T (44,45). A similar effect of anti-IFN-y monoclonal antibody was observed in the mouse model of experimental autoimmune uveoretinitis (46 (13)(14)(15)(16)(17).…”
Section: Discussionsupporting
confidence: 50%
“…In addition to antigen or anti-CD3-induced IFN-y production by T (44,45). A similar effect of anti-IFN-y monoclonal antibody was observed in the mouse model of experimental autoimmune uveoretinitis (46 (13)(14)(15)(16)(17).…”
Section: Discussionsupporting
confidence: 50%
“…[31][32][33] IFN-g belongs to a group of proinflammatory cytokines produced by Th1 cells. EAE disease activity, therefore, appears to be determined by more factors than just Th1/Th2 skewing of SP or LN lymphocytes.…”
Section: Discussionmentioning
confidence: 99%
“…IFN-g-producing Th1 cells were associated with MS lesions (21), and recombinant IFN-g exacerbated disease in MS patients (22). However, in experimental autoimmune encephalomyelitis (EAE), neutralizing IFN-g in vivo (23,24) or targeting the Ifng gene (25,26) or the Ifngr gene (27) increased EAE mortality, whereas intraventricular IFN-g administration suppressed EAE (28).…”
mentioning
confidence: 99%